PhilipPConnellMD

Associate Professor of Radiation and Cellular Oncology, University of Chicago Medicine

Dr. Connell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Fax+1 773-834-7340

University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1996 - 2000
Westchester Medical CenterInternship, Internal Medicine, 1995 - 1996
New York Medical CollegeClass of 1995

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
Rohan R Katipally, Liam F Spurr, Stanley I Gutiontov, William Tyler Turchan, Philip Connell
JCO Precision Oncology. 2023-01-01
5 citations
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
Liam F Spurr, Carlos A Martinez, Rohan R Katipally, Soumya C Iyer, Sian A Pugh
NPJ Precision Oncology. 2022-10-14
7 citations
Noncanonical NF-κB factor p100/p52 regulates homologous recombination and modulates sensitivity to DNA-damaging therapy.
Brian Budke, Alison Zhong, Katherine Sullivan, Chanyoung Park, David I Gittin
Nucleic Acids Research. 2022-06-24

RAD51 Inhibitors For Chemotherapy And Radiation TherapyNational Cancer Institute2010–2012
Inhibition Of Recombination DNA Repair In Pancreatic Cancer CellsNational Cancer Institute2007–2008